Gastroenterology & Acid-Peptic Disorders
High-precision gastrointestinal formulations targeting erosive and non-erosive GERD, peptic ulceration, and functional dyspepsia with accelerated mucosal healing.
Clinical Overview & Pathophysiology
In this therapeutic area, Icon Drugs formulates high-stability compounds meeting pharmacopeial limits for content uniformity, dissolution rates, and organic impurities. Our manufacturing adheres to verified batch repeatability so prescribing clinicians can depend upon predictable bioavailability.
For complete bioequivalence dossiers, stability monographs, or hospital tender supply parameters in Gastroenterology & Acid-Peptic Disorders, please contact our Medical Affairs or Business Enquiry team.
Indications & Conditions5 Addressed
- GERD
- Erosive Esophagitis
- Peptic & Duodenal Ulcers
- Functional Dyspepsia
- Bile Reflux
Formulations in Gastroenterology & Acid-Peptic Disorders
Active pharmaceutical formulations manufactured under WHO-GMP compliance
Pandom / Pandom-SR
“Controls Acid & Reflux — The GI Fire Extinguisher”
Pantoprazole 40 mg + Domperidone 10 mg / 30 mg SR
Rabicon / Rabicon-L
“Erases Acid, Regulates Motility — Greater Success in Reflux”
Rabeprazole Sodium 20 mg (± Levosulpiride 75 mg SR)